feed,title,long_url,short_url
Benzinga,Multiple Sclerosis Drugs Market Worth $40.66 Bn at 7.1% CAGR; Industry Bigwigs Such as Novartis and Biogen to Focus on Introducing Cost-Effective MS Treatments: Fortune Business Insightsâ„¢,https://www.benzinga.com/pressreleases/20/08/g17206267/multiple-sclerosis-drugs-market-worth-40-66-bn-at-7-1-cagr-industry-bigwigs-such-as-novartis-and-b,https://j.mp/2YugOnO
